CA
ABBV icon

Carson Advisory’s AbbVie ABBV Stock Holding History

Carson Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Buy
2,694
+6
+0.2% +$1.29K 0.31% 76
2026
Q1 		$585K Sell
2,688
-10
-0.4% -$2.22K 0.3% 77
2025
Q4 		$616K Sell
2,698
-7
-0.3% -$1.59K 0.32% 75
2025
Q3 		$626K Sell
2,705
-4
-0.1% -$815 0.34% 68
2025
Q2 		$503K Buy
2,709
+256
+10% +$47.6K 0.32% 73
2025
Q1 		$514K Sell
2,453
-25
-1% -$4.86K 0.35% 70
2024
Q4 		$440K Hold
2,478
– – 0.31% 75
2024
Q3 		$489K Sell
2,478
-25
-1% -$4.67K 0.31% 82
2024
Q2 		$429K Sell
2,503
-76
-3% -$12.6K 0.3% 87
2024
Q1 		$470K Sell
2,579
-50
-2% -$8.62K 0.33% 87
2023
Q4 		$407K Buy
2,629
+24
+0.9% +$3.5K 0.32% 90
2023
Q3 		$388K Sell
2,605
-110
-4% -$16.1K 0.34% 90
2023
Q2 		$366K Buy
2,715
+14
+0.5% +$2.05K 0.31% 92
2023
Q1 		$430K Sell
2,701
-97
-3% -$14.8K 0.38% 78
2022
Q4 		$452K Sell
2,798
-500
-15% -$76.7K 0.43% 63
2022
Q3 		$443K Buy
3,298
+473
+17% +$67.9K 0.49% 61
2022
Q2 		$433K Hold
2,825
– – 0.48% 61
2022
Q1 		$458K Buy
2,825
+100
+4% +$14.5K 0.46% 62
2021
Q4 		$369K Buy
+2,725
New +$322K 0.37% 73

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Carson Advisory's ABBV Position: Q2 2026 in Review

Carson Advisory increased its AbbVie (ABBV) stake by 0.22% in Q2 2026, buying an estimated $1.29K and bringing the position to 2,694 shares worth $678K. The position accounts for 0.31% of the portfolio, ranked #76.

Carson Advisory first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Carson Advisory held 2,694 shares of AbbVie worth $678K as of Q2 2026.
  • Carson Advisory bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.31% of Carson Advisory's portfolio in Q2 2026, its #76 holding.
  • Carson Advisory first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Carson Advisory's 13F filing for Q2 2026, filed 11 Aug 2026.